Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Godavari Drugs Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Godavari Drugs Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Godavari Drugs Q4 net profit down 66.54% at Rs 0.89 cr

    30 May 2025, 4:55PM The company reported standalone net profit of Rs 0.89 crore for the quarter ended March 31, 2025 as compared to Rs 2.66 crore in the same period last
  • Godavari Drugs - INTIMATION FOR RE-CONSTITUTION OF COMMITTEES OF THE BOARD

    29 May 2025, 7:35PM Intimation for Re-Constitution of Audit Committee, Nomination and Remuneration Committee and Stake Holders and Relationship Committee
  • Godavari Drugs - Announcement under Regulation 30 (LODR)-Change in Management

    29 May 2025, 7:32PM Appointment of Independent Director, Internal Auditor, Secretarial Auditor, Cost Auditor and to take note of Completion of Tenure of Independent Direc
  • Godavari Drugs - AUDITED STANDALONE FINANCIALS OF THE COMPANY FOR THE QUARTER AND YEAR ENDED ON 31-03-2025

    29 May 2025, 7:24PM Audited Standalone Financials of the Company for the Quarter and Year Ended on 31.03.2025
  • Godavari Drugs - Board Meeting Outcome for Outcome Of The Board Meeting Of Godavari Drugs Limited Held On Thursday 29Th May,

    29 May 2025, 7:13PM Outcome of Board Meeting
  • Godavari Drugs - Board Meeting Intimation for Approval Of The Audited Financial Results Of The Company Along With Audit Repor

    24 May 2025, 5:03PM Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and a
  • Godavari Drugs has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    17 Apr 2025, 3:20PM As of March 2025, 52.63% is owned by Indian Promoters and 47.37% by Public. <p align=justify> Top five Promoters holding highest number of shares of G
  • Godavari Drugs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    14 Apr 2025, 11:05AM Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018 is enclosed

Key fundamentals

Evaluate the intrinsic value of Godavari Drugs Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 94.5909 66.9135 49.9747 52.4646 46.3334
Liabilities 94.5909 66.9135 49.9747 52.4646 46.3334
Equity 7.5305 7.5305 7.5305 7.5305 7.5305
Gross Profit 13.3043 9.9208 11.29 9.8269 6.0353
Net Profit 5.5489 3.7858 5.2453 4.128 2.0007
Cash From Operating Activities 18.4136 13.2171 11.2298 1.3278 6.2435
NPM(%) 3.54 2.37 3.25 3.36 2.09
Revenue 156.7119 159.6248 161.1062 122.6701 95.6977
Expenses 143.4076 149.704 149.8162 112.8432 89.6624
ROE(%) 12.8 8.73 12.1 9.52 4.61

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Godavari Drugs Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 859.90 1.12 28.38 55.18 301.39 0.58
Lotus Eye Hospital and Institute Ltd 72.27 -2.54 205.89 201.06 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 26.00 1.13 0.00 417.46 -39.50 0.00
Astec Lifesciences Ltd 806.15 -0.38 0.00 189.58 -687.10 0.00

Company Info

GODAVARI DRUGS LIMITED was incorporated as a private limited company on December 2nd 1987 and subsequently converted into a public limited company on September 25th 1992. It was promoted by Mr. Ghanshyam Jaju, Mr. Mukund Kakani and Mr. P.C. Shrimal. The company has set up a project to manufacture 180 TPA at SULPHAMETHOXAZOLE (SMX) in 1988. The project is located at Maharashtra Industrial Development Corporation (MIDC), Nanded, a notified class 'C' backward district in Maharashtra. The project was fully commissioned on July 3rd 1989. MAIN OBJECTS OF THE COMPANY: The main objects at the Company as detailed in the Memorandum at Association of the Company are: 1. To manufacture, refine, purchase, sell, prepare, import, export all classes and kinds of drugs including pharmaceutical preparations and formulations, fine organics and inorganic chemicals, raw materials and intermediates for drugs. 2. To manufacture and/or deal in all types at drugs, chemicals, pharmaceuticals and intermediates on loan licence basis. 3. To undertake, promote, encourage, initiate, assist and engage in all kinds of research and development work and to set up laboratories and other facilities required for the same to render such assistance, monetary or otherwise, as may be required for the purpose. 2012 -Godavari Drugs Ltd has informed that the Board has appointed Mr. Mohit Jaju as an Additional Director effective from May 10, 2012

GODAVARI DRUGS LIMITED was incorporated as a private limited company on December 2nd 1987 and subsequently converted into a public limited company on September 25th 1992. It was promoted by Mr. Ghanshyam Jaju, Mr. Mukund Kakani and Mr. P.C. Shrimal. The company has set up a project to manufacture 180 TPA at SULPHAMETHOXAZOLE (SMX) in 1988. The project is located at Maharashtra Industrial Development Corporation (MIDC), Nanded, a notified class 'C' backward district in Maharashtra. The project was fully commissioned on July 3rd 1989. MAIN OBJECTS OF THE COMPANY: The main objects at the Company as detailed in the Memorandum at Association of the Company are: 1. To manufacture, refine, purchase, sell, prepare, import, export all classes and kinds of drugs including pharmaceutical preparations and formulations, fine organics and inorganic chemicals, raw materials and intermediates for drugs. 2. To manufacture and/or deal in all types at drugs, chemicals, pharmaceuticals and intermediates on loan licence basis. 3. To undertake, promote, encourage, initiate, assist and engage in all kinds of research and development work and to set up laboratories and other facilities required for the same to render such assistance, monetary or otherwise, as may be required for the purpose. 2012 -Godavari Drugs Ltd has informed that the Board has appointed Mr. Mohit Jaju as an Additional Director effective from May 10, 2012

Read More

Parent Organisation

Godavari Drugs Ltd.

Founded

02/12/1987

Managing Director

Mr.Mukund Kakani

NSE Symbol

FAQ

The current price of Godavari Drugs Ltd is

The 52-week high for Godavari Drugs Ltd is

The market capitalization of Godavari Drugs Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Godavari Drugs Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Godavari Drugs Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Godavari Drugs Ltd shares.

The CEO of Godavari Drugs Ltd is Mr.Mukund Kakani, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT